Cargando…

Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases

BACKGROUND & AIMS: Exposure to hormone contraception has been associated with an increased risk of relapse of inflammatory bowel diseases (IBD). Little is known about the effects of cancer therapies, specifically hormone therapies, on the course of IBD. METHODS: We conducted a retrospective coho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Axelrad, Jordan E., Bazarbashi, Ahmad, Zhou, James, Castañeda, Daniel, Gujral, Amandeep, Sperling, Dylan, Glass, Jason, Agrawal, Manasi, Hong, Simon, Lawlor, Garrett, Hudesman, David, Chang, Shannon, Shah, Shailja, Yajnik, Vijay, Ananthakrishnan, Ashwin, Khalili, Hamed, Colombel, Jean-Frederic, Itzkowitz, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354097/ https://www.ncbi.nlm.nih.gov/pubmed/31302306 http://dx.doi.org/10.1016/j.cgh.2019.06.042

Ejemplares similares

Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance
por: Mahmoud, Remi, et al.
Publicado: (2019)

No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases
por: Mahmoud, Remi, et al.
Publicado: (2018)

Changing epidemiology of immune-mediated inflammatory diseases in immigrants: a systematic review of population-based studies
por: Agrawal, Manasi, et al.
Publicado: (2019)

The role of gastrointestinal pathogens in inflammatory bowel disease: a systematic review
por: Axelrad, Jordan E., et al.
Publicado: (2021)

Su1482: SCOUT IBD: SURVEILLANCE OF COVID-19 IMPACT ON LONG-TERM OUTCOMES IN IBD
por: Hong, Simon J., et al.
Publicado: (2022)

Su1483: COVID-19 VACCINES ARE HIGHLY EFFECTIVE IN PATIENTS WITH IBD: OUTCOMES FROM THE SCOUT IBD COHORT
por: Hong, Simon J., et al.
Publicado: (2022)

COVID-19 is not associated with worse long-term inflammatory bowel disease outcomes: a multicenter case–control study
por: Hong, Simon J., et al.
Publicado: (2022)

Early life exposures and the risk of inflammatory bowel disease: Systematic review and meta-analyses
por: Agrawal, Manasi, et al.
Publicado: (2021)

Identification and Characterization of a Novel Association between Dietary Potassium and Risk of Crohn’s Disease and Ulcerative Colitis
por: Khalili, Hamed, et al.
Publicado: (2016)

Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission
por: George, Lauren A, et al.
Publicado: (2023)

Management of IBD-Associated Dysplasia in the Modern Era
por: Shah, Shailja C., et al.
Publicado: (2019)

JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications
por: Agrawal, Manasi, et al.
Publicado: (2020)

Early life environment and natural history of inflammatory bowel diseases
por: Guo, Abra Y, et al.
Publicado: (2014)

Knowledge Gaps among Physicians Caring for Multiethnic Populations at Increased Gastric Cancer Risk
por: Shah, Shailja C., et al.
Publicado: (2018)

Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease
por: Shah, Shailja C., et al.
Publicado: (2019)

Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era
por: Axelrad, Jordan E., et al.
Publicado: (2020)

Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective
por: Axelrad, Jordan E, et al.
Publicado: (2016)

Cancer risk in microscopic colitis: a retrospective cohort study
por: Levy, Alexander, et al.
Publicado: (2019)

Impact of Diet on Risk of IBD
por: Ananthakrishnan, Ashwin N
Publicado: (2020)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

Upper Endoscopy up to 3 Years Prior to a Diagnosis of Gastric Cancer Is Associated With Lower Stage of Disease in a USA Multiethnic Urban Population, a Retrospective Study
por: Shah, Shailja C., et al.
Publicado: (2019)

Clinical Characteristics and Treatment Response in Microscopic Colitis Based on Age at Diagnosis: A Multicenter Retrospective Study
por: Kamboj, Amrit K., et al.
Publicado: (2021)

Endogenous Levels of Circulating Androgens and Risk of Crohn's Disease and Ulcerative Colitis Among Women: A Nested Case–Control Study from the Nurses' Health Study Cohorts
por: Khalili, Hamed, et al.
Publicado: (2015)

Real-World Effectiveness and Safety of Ustekinumab for Ulcerative Colitis From 2 Tertiary IBD Centers in the United States
por: Hong, Simon J, et al.
Publicado: (2021)

Structural Insights Into Key Plasmodium Proteases as Therapeutic Drug Targets
por: Mishra, Manasi, et al.
Publicado: (2019)

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
por: Haberman, Rebecca, et al.
Publicado: (2020)

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry
por: Ungaro, Ryan C., et al.
Publicado: (2022)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY
por: Ungaro, Ryan C., et al.
Publicado: (2021)

Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses’ Health Study cohorts
por: Khalili, Hamed, et al.
Publicado: (2013)

Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case–control study
por: Sahay, Tanya, et al.
Publicado: (2014)

The Doctor Will Call You Now! Telemedicine in the Midst of a Pandemic
por: Ananthakrishnan, Ashwin N., et al.
Publicado: (2020)

Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review
por: Gupta, Akshita, et al.
Publicado: (2021)

Autoimmune and Chronic Inflammatory Disease Patients with COVID‐19
por: Ungaro, Ryan C., et al.
Publicado: (2021)

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease
por: Parekh, Rajen, et al.
Publicado: (2021)

Clomiphene citrate-induced visual hallucinations: a case report
por: Venkatesh, Ramesh, et al.
Publicado: (2017)

Pivot to Asia: inflammatory bowel disease burden
por: Singh, Prashant, et al.
Publicado: (2017)

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE
por: Spiera, Emily, et al.
Publicado: (2022)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hh6o131jts7cvvu7ji4dmh1cf6